KG Simon

2.1k total citations
9 papers, 981 citations indexed

About

KG Simon is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, KG Simon has authored 9 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Oncology. Recurrent topics in KG Simon's work include Multiple Sclerosis Research Studies (4 papers), Viral Infections and Immunology Research (2 papers) and Viral-associated cancers and disorders (2 papers). KG Simon is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Viral Infections and Immunology Research (2 papers) and Viral-associated cancers and disorders (2 papers). KG Simon collaborates with scholars based in United States, Germany and Australia. KG Simon's co-authors include Alberto Ascherio, Kassandra L. Munger, Philip L. De Jager, David A. Hafler, Xing Yang, John D. Rioux, Terence Dwyer, Ingrid van der Mei, Peter Sundström and Anne‐Louise Ponsonby and has published in prestigious journals such as Neurology, The Lancet Neurology and Multiple Sclerosis Journal.

In The Last Decade

KG Simon

9 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
KG Simon United States	6	746	355	153	131	126	9	981
Maria Bäärnhielm Sweden	8	718 1.0×	321 0.9×	100 0.7×	84 0.6×	124 1.0×	9	940
Marja‐Liisa Sumelahti Finland	16	653 0.9×	179 0.5×	145 0.9×	98 0.7×	157 1.2×	45	911
D. A. Dyment Canada	14	768 1.0×	541 1.5×	170 1.1×	85 0.6×	83 0.7×	18	1.1k
Sarah-Michelle Orton United Kingdom	10	1.1k 1.4×	430 1.2×	115 0.8×	95 0.7×	100 0.8×	11	1.4k
P. O’Connor Canada	10	783 1.0×	233 0.7×	152 1.0×	242 1.8×	87 0.7×	16	1.0k
Andreia Bettencourt Portugal	18	264 0.4×	215 0.6×	158 1.0×	42 0.3×	83 0.7×	39	761
Wendy Dankers Netherlands	10	341 0.5×	350 1.0×	115 0.8×	97 0.7×	21 0.2×	19	774
Dirk Pleimes Germany	11	496 0.7×	165 0.5×	105 0.7×	76 0.6×	69 0.5×	28	659
Xiaorong Shao United States	13	297 0.4×	144 0.4×	101 0.7×	95 0.7×	50 0.4×	24	639
Stine Marit Moen Norway	15	469 0.6×	139 0.4×	88 0.6×	45 0.3×	87 0.7×	26	611

Countries citing papers authored by KG Simon

Since Specialization

Citations

This map shows the geographic impact of KG Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KG Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KG Simon more than expected).

Fields of papers citing papers by KG Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KG Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KG Simon. The network helps show where KG Simon may publish in the future.

Co-authorship network of co-authors of KG Simon

This figure shows the co-authorship network connecting the top 25 collaborators of KG Simon. A scholar is included among the top collaborators of KG Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KG Simon. KG Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Christensen, Steen Bach, Albrecht Stoehr, Markus Cornberg, et al.. (2019). High real-world effectiveness of elbasvir/grazoprevir (EBR/GZR) in PWID on opioid substitution therapy with HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R). Zeitschrift für Gastroenterologie. 1 indexed citations

Vermehren, Johannes, Albrecht Stoehr, Julian Schulze zur Wiesch, et al.. (2018). Re-Therapie von DAA-Versagern mit Sofosbuvir/Velpatasvir/Voxilaprevir – Ergebnisse aus dem Deutschen Hepatitis C-Register (DHC-R). Zeitschrift für Gastroenterologie. 56(8). e290–e290. 1 indexed citations

Massa, Jennifer, Ayad Hamdan, KG Simon, et al.. (2012). Infectious mononucleosis and risk of breast cancer in a prospective study of women. Cancer Causes & Control. 23(12). 1893–1898. 4 indexed citations

Simon, KG, Ingrid van der Mei, Anne‐Louise Ponsonby, et al.. (2010). Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology. 74(17). 1365–1371. 103 indexed citations

Ascherio, Alberto, Kassandra L. Munger, & KG Simon. (2010). Vitamin D and multiple sclerosis. The Lancet Neurology. 9(6). 599–612. 427 indexed citations

Simon, KG, et al.. (2010). EBNA1 and LMP1 variants in multiple sclerosis cases and controls. Acta Neurologica Scandinavica. 124(1). 53–58. 13 indexed citations

Jager, Philip L. De, Lori B. Chibnik, Jing Cui, et al.. (2009). Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. The Lancet Neurology. 8(12). 1111–1119. 186 indexed citations

Simon, KG, Kassandra L. Munger, Xing Yang, & Alberto Ascherio. (2009). Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis Journal. 16(2). 133–138. 112 indexed citations

Jager, Philip L. De, KG Simon, Kassandra L. Munger, et al.. (2008). Integrating risk factors. Neurology. 70(13_part_2). 1113–1118. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact